Chinese General Practice ›› 2025, Vol. 28 ›› Issue (11): 1411-1416.DOI: 10.12114/j.issn.1007-9572.2023.0884
Special Issue: 消化系统疾病最新文章合辑
• Review & Perspectives • Previous Articles Next Articles
Received:
2023-11-10
Revised:
2024-02-06
Published:
2025-04-15
Online:
2025-02-06
Contact:
DONG Mingguo
通讯作者:
董明国
作者简介:
作者贡献:
王宇新负责文章的构思与设计、研究资料的收集与整理、绘制表格、论文撰写;彭文婉、周正负责论文修订;黄海阳、卢晓敏负责文章的质量控制及审校;董明国负责论文修订、文章的质量控制及审校,对文章整体负责、监督管理。
基金资助:
CLC Number:
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.chinagp.net/EN/10.12114/j.issn.1007-9572.2023.0884
评估方法 | 胃黏膜萎缩 | 肠化 |
---|---|---|
内镜下评估 | 木村-竹本分型开放型 | EGGIM≥5分 |
病理组织学评估 | OLGA Ⅲ、Ⅳ期 | OLGIM Ⅲ、Ⅳ期 |
生物标志物评估 | PG Ⅰ≤70 ng/mL,PGR≤3 | 不完全型 |
Table 1 Evaluation methods of patients with high risk of carcinogenesis in gastric precancerous conditions
评估方法 | 胃黏膜萎缩 | 肠化 |
---|---|---|
内镜下评估 | 木村-竹本分型开放型 | EGGIM≥5分 |
病理组织学评估 | OLGA Ⅲ、Ⅳ期 | OLGIM Ⅲ、Ⅳ期 |
生物标志物评估 | PG Ⅰ≤70 ng/mL,PGR≤3 | 不完全型 |
[1] |
|
[2] |
|
[3] |
|
[4] |
国家消化系疾病临床医学研究中心(上海),国家消化道早癌防治中心联盟,中华医学会消化病学分会幽门螺杆菌学组,等. 中国胃黏膜癌前状态和癌前病变的处理策略专家共识(2020年)[J]. 中华消化杂志,2020,40(11):731-741. DOI:10.3760/cma.j.cn311367-20200915-00554.
|
[5] |
|
[6] |
|
[7] |
|
[8] |
|
[9] |
中华医学会消化病学分会,中华医学会消化病学分会消化系统肿瘤协作组. 中国慢性胃炎诊治指南(2022年,上海)[J]. 中华消化杂志,2023,43(3):145-175. DOI:10.3760/cma.j.cn311367-20230117-00023.
|
[10] |
|
[11] |
|
[12] |
|
[13] |
中华医学会病理分会消化病理学组筹备组. 慢性胃炎及上皮性肿瘤胃黏膜活检病理诊断共识[J]. 中华病理学杂志,2017,46(5):289-293. DOI:10.3760/cma.j.issn.0529-5807.2017.05.001.
|
[14] |
赫捷,陈万青,李兆申,等. 中国胃癌筛查与早诊早治指南(2022,北京)[J]. 中华肿瘤杂志,2022,44(7):634-666. DOI:10.3760/cma.j.cn112152-20220617-00430.
|
[15] |
卞立群,王凤云,陈婷,等. 《中药新药用于慢性胃炎的临床疗效评价技术指导原则》中萎缩性胃炎与癌前病变内容解读[J]. 中国中西医结合消化杂志,2023,31(5):323-326. DOI:10.3969/j.issn.1671-038X.2023.05.02.
|
[16] |
|
[17] |
|
[18] |
|
[19] |
|
[20] |
|
[21] |
时永全,陈敏,王学红,等. 慢性萎缩性胃炎诊疗和羔羊胃提取物维B12临床应用专家指导意见[J]. 中华消化杂志,2022,42(9):577-584. DOI:10.3760/cma.j.cn311367-20220630-00316.
|
[22] |
|
[23] |
|
[24] |
|
[25] |
|
[26] |
|
[27] |
|
[28] |
|
[29] |
|
[30] |
|
[31] |
吉跃进,沈洪,朱磊. 中药治疗慢性萎缩性胃炎研究进展[J]. 中华中医药学刊,2021,39(5):166-170,后插31. DOI:10.13193/j.issn.1673-7717.2021.05.040.
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
|
[37] |
|
[38] |
李文茜,王学红,朱思雨,等. 胃炎及胃癌患者血清HIF-1α和ROS表达水平与Hp感染的关系及临床意义[J]. 检验医学与临床,2023,20(11):1532-1535.
|
[39] |
|
[40] |
吴雨昊. HIF-1α/HO-1介导的细胞铁死亡在DEHP致未成熟睾丸发育损伤中的作用及机制研究[D]. 重庆:重庆医科大学,2022.
|
[41] |
|
[42] |
张家祥,周永学,闫曙光,等. 缺氧诱导的线粒体自噬与糖代谢重编程对胃癌前病变影响的研究进展[J]. 中国癌症杂志,2022,32(10):1007-1015. DOI:10.19401/j.cnki.1007-3639.2022.10.009.
|
[43] |
|
[44] |
|
[45] |
|
[46] |
|
[47] |
刘伟,倪家慧,张丹,等. 中医药调控胃"炎癌转化"癌前微环境的思考与策略[J]. 中华中医药杂志,2023,38(4):1431-1435.
|
[48] |
吴皓萌,黄绍刚,王凤云,等. 基于胃微环境探讨中医药防治胃癌前病变的机制[J]. 中国实验方剂学杂志,2021,27(16):245-250. DOI:10.13422/j.cnki.syfjx.20211697.
|
[49] |
|
[50] |
|
[51] |
|
[52] |
马佳乐,李慧臻,赵双梅,等. 中医药通过调控自噬治疗胃癌及癌前病变的研究现状[J]. 中国实验方剂学杂志,2021,27(4):233-239. DOI:10.13422/j.cnki.syfjx.20202228.
|
[53] |
梁绮婷,杨良俊,郑嘉怡,等. 基于"脾为谏议之官"理论探讨脾虚病机与胃癌前病变细胞焦亡的相关性[J]. 中华中医药杂志,2020,35(5):2453-2456.
|
[54] |
|
[55] |
|
[56] |
|
[57] |
|
[58] |
|
[59] |
|
[1] | TIAN Chen, LIU Jianing, TIAN Jinhui, GE Long. Living Systematic Reviews: Methods and Processes for Development [J]. Chinese General Practice, 2025, 28(30): 3853-3860. |
[2] | WANG Tingting, TANG Yong, ZHANG Wenke, LI Zhigang. Research Progress on Exercise Intervention of Hyperuricemia [J]. Chinese General Practice, 2025, 28(30): 3841-3846. |
[3] | ZHOU Sheng, DENG Changsheng, ZOU Guanyang, SONG Jianping. Research Progress on the Pathogenesis of Complications of Malaria in Cardiovascular Diseases [J]. Chinese General Practice, 2025, 28(27): 3466-3472. |
[4] | HUANG Yulin, WANG Haoyun, LI Yanmei, XIAO Xueying. Symptom Clusters in Gastric Cancer Patients Receiving Chemotherapy: a Scoping Review [J]. Chinese General Practice, 2025, 28(26): 3338-3344. |
[5] | LI Miaoxiu, ZHU Bowen, KONG Lingjun, FANG Min. Progress in Research on Clinical Assessment Tools for Conservative Treatment of Adolescent Idiopathic Scoliosis [J]. Chinese General Practice, 2025, 28(24): 3079-3088. |
[6] | LIU Yinyin, SUI Hongping, LI Tingting, JIANG Tongtong, SHI Tieying, XIA Yunlong. Advances in Risk Prediction Models for Cardiotoxicity Associated with Breast Cancer Treatment [J]. Chinese General Practice, 2025, 28(24): 3072-3078. |
[7] | XIAO Yao, WAN Jun. Treatment of Venous Thromboembolism in Special Populations with Direct Oral Anticoagulants [J]. Chinese General Practice, 2025, 28(24): 3066-3071. |
[8] | RUAN Wanbai, LI Junfeng, YIN Yanmei, PENG Lei, ZHU Kexiang. Research Progress of Targeted Therapy and Immunotherapy for Pancreatic Cancer [J]. Chinese General Practice, 2025, 28(23): 2950-2960. |
[9] | ZHOU Lianpeng, LI Weifeng, DONG Xingang, WANG Xiaoyuan. Research Progress on the Role of Copper Homeostasis Regulation Mechanism in Cognition Disorder [J]. Chinese General Practice, 2025, 28(23): 2941-2949. |
[10] | ZHOU Qian, WU Xiaomin, WANG Baohua, YAN Ruohan, YU Miao, WU Jing. Study on Nomogram Prediction Model for Risk of Gastric Cancer [J]. Chinese General Practice, 2025, 28(23): 2870-2877. |
[11] | DONG Haocheng, HAO Xiao, AN Dong, LI Haohan, LI Shuren. Research Progress of Heart Failure with Supra-normal Ejection Fraction [J]. Chinese General Practice, 2025, 28(21): 2692-2696. |
[12] | DU Qiongliang, LIN Bailang, GUO Honghua. Research Progress and Implications of Group Well-child Care [J]. Chinese General Practice, 2025, 28(21): 2672-2678. |
[13] | WEN Yongxia, SUN Hai, CHEN Xiaoju, CAI Wanjing, LI Shuni, GUO Honghua. A Systematic Review of the Assessment Tools for Maternal Psychological Birth Trauma [J]. Chinese General Practice, 2025, 28(20): 2555-2561. |
[14] | CHU Tianyu, GU Yan. Carotid Artery Calcification Features in Plaque Stability and Clinical Events [J]. Chinese General Practice, 2025, 28(18): 2247-2252. |
[15] | ZHU Ziyi, HE Guixin, QIN Weibin, SONG Hui, ZHANG Liwen, TANG Weizhi, YANG Feifei, LIU Lingyun, OUYANG Bin. Research Progress of Mitochondrial Autophagy in Improving Myocardial Fibrosis after Myocardial Infarction and Intervention of Traditional Chinese Medicine [J]. Chinese General Practice, 2025, 28(18): 2294-2300. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||